Country Overview (Pharma & Healthcare)


Publication Single User License (PDF) Price
Production and Market of Chinese Dental Laser Industry 2015-2020 Proposal

Production and Market of Chinese Dental Laser Industry 2015-2020 Proposal

Date Published: Jun 25 2015
Dental laser is a new treatment for oral medicine, and it has about 6 kinds of laser had applied to medical treatment, e.g. CO₂, Nd: YAG, Diode, Er:YAG, Er, Cr: YSGG, and Nd: YAP. Compare to western countries, China is underdevelopment in dental laser equipment realm, and clinic application as well. Base on the research from AskCI, 1,500 dental lasers had produced in China in 2014, that market cap worth 300 million.
 
$3,500.00
Market Analysis of Overseas Medical Services Agency Industry in China 2015-2020 Proposal

Market Analysis of Overseas Medical Services Agency Industry in China 2015-2020 Proposal

Date Published: Jun 25 2015
According to Transparency Market Research, the market scale of global medical tourism market will grow from USD10 billion to USD30 billion by 2019. Medical organizations from countries such as US, Japan, South Korea, etc. have introduced businesses in China.  Take Massachusetts General Hospital as an example, it has taken 40 Chinese patients in 2012, which rose to about 100 in 2013. By 2014, there were over 100,000 patients waiting for overseas medical treatment in China. 
 
$3,500.00
Spain Pharmaceuticals and Healthcare Report Q3 2015

Spain Pharmaceuticals and Healthcare Report Q3 2015

Date Published: Jun 24 2015
Spain's non-transparent and unpredictable government medicine pricing system and the implementation of numerous emergency measures to contain pharmaceutical spending will highly disrupt multinational drugmakers' strategy and revenue streams. Despite the Spanish economy exiting crisis mode, we believe that the Spanish government will continue to target the healthcare sector - a large recipient of government funds. As a result, we uphold our bearish outlook for the Spanish pharmaceutical market over the next five years.
 
$1,295.00
Sri Lanka Pharmaceuticals and Healthcare Report Q3 2015

Sri Lanka Pharmaceuticals and Healthcare Report Q3 2015

Date Published: Jun 24 2015
Domestic generic drugmakers will be at a distinct advantage under Sri Lanka's proposed national medicinal policy. With directives boosting generic drug sales through generic substitution, local pharmaceutical companies will be further assisted as the government aims to use the policy to reduce medicine imports. We highlight that these changes will come at the expense of drugmakers in India and Bangladesh, which have been a key source of pharmaceutical imports into Sri Lanka.
 
$1,295.00
Ghana Medical Devices Report Q3 2015

Ghana Medical Devices Report Q3 2015

Date Published: Jun 24 2015
Ghana represents a comparatively small medical device market of just under USD60mn. Per capita spending is low at USD2.3 indicating considerable potential for expansion. Primarily supplied by imports, the market has enjoyed one of the world's highest CAGRs over the 2008-2013 period, but a sharp contraction in the market in 2013 and 2014 will result in slower growth being registered over the 2013-2018 period.
 

Headline Industry Forecasts 

$1,295.00
Kenya Medical Devices Report Q3 2015

Kenya Medical Devices Report Q3 2015

Date Published: Jun 24 2015
We expect the Kenyan medical device market to grow by a CAGR of 14.4% over the 2013-2018 period, alongside impressive GDP growth and strengthening imports. Almost all medical devices are imported, as domestic production is limited to basic consumable items, a situation that is expected to remain unchanged for the foreseeable future. Demand for medical devices remains high as many health facilities require modernisation.
 

Headline Industry Forecasts 

$1,295.00
Belgium Pharmaceuticals and Healthcare Report Q3 2015

Belgium Pharmaceuticals and Healthcare Report Q3 2015

Date Published: Jun 24 2015
$1,295.00
Indonesia Pharmaceuticals and Healthcare Report Q3 2015

Indonesia Pharmaceuticals and Healthcare Report Q3 2015

Date Published: Jun 24 2015
Indonesia's healthcare expenditure will grow robustly. Key to this trajectory is rising household incomes which will have strong positive ramifications due to the dominant role of private spending as a source of healthcare financing. This will be further augmented by the roll out of universal healthcare which will improve access to medical services and in turn create commercial opportunities that will drive the expansion of private hospitals - a boon to Indonesia's healthcare infrastructure.
 
$1,295.00
Namibia Pharmaceuticals and Healthcare Report Q3 2015

Namibia Pharmaceuticals and Healthcare Report Q3 2015

Date Published: Jun 24 2015
$1,295.00
Qatar Pharmaceuticals and Healthcare Report Q3 2015

Qatar Pharmaceuticals and Healthcare Report Q3 2015

Date Published: Jun 24 2015
Qatar's Annual Health Report for 2014 confirms our view that the healthcare sector will experience strong growth over our forecast period. Sizeable expansion projects are underway, health insurance coverage is increasing and government spending will remain elevated given the substantial reserves. Growing private sector engagement will also drive healthcare market growth.
 

Headline Expenditure Projections 

$1,295.00
Serbia Pharmaceuticals and Healthcare Report Q3 2015

Serbia Pharmaceuticals and Healthcare Report Q3 2015

Date Published: Jun 24 2015
A focus on reining in Serbia's bloated public sector following an agreement with the IMF will inevitably lead to cuts in healthcare spending. Furthermore, Serbia's healthcare authorities will continue to cut prices to reduce their pharmaceutical expenditure as a means to contain healthcare costs. We expect the growth outlook for the Serbian pharmaceutical market to worsen in the short-term as household and government consumption decline.
 

Headline Expenditure Projections

$1,295.00
Hungary Medical Devices Report Q3 2015

Hungary Medical Devices Report Q3 2015

Date Published: Jun 17 2015
We expect the Hungarian medical device market to fall by a CAGR of 0.4% over the 2013-2018 period, although the growth rate in local currency terms is more encouraging at 3.1%. Hungary is heavily reliant on imported medical devices despite a growing domestic industry. Manufacturers tend to concentrate on exports, most of which are shipped to Western Europe. The comprehensive public hospital sector and expanding private sector will retain the demand for medical devices.
 

Headline Industry Forecasts 

$1,295.00
Iran Pharmaceuticals and Healthcare Report Q3 2015

Iran Pharmaceuticals and Healthcare Report Q3 2015

Date Published: Jun 17 2015
The gradual easing of sanctions in Iran will lead to an uptick in interest from multinational pharmaceutical companies, many of which chose not to do business in Iran during this time. The supply of high value patented medicines will still be satisfied by multinationals despite increasing competition from domestic companies, with the easing of sanctions providing a more attractive operating environment.
 

Headline Expenditure Projections 

$1,295.00
Japan Medical Devices Report Q3 2015

Japan Medical Devices Report Q3 2015

Date Published: Jun 17 2015
$1,295.00
Ireland Pharmaceuticals and Healthcare Report Q3 2015

Ireland Pharmaceuticals and Healthcare Report Q3 2015

Date Published: Jun 17 2015
$1,295.00
Oman Medical Devices Report Q3 2015

Oman Medical Devices Report Q3 2015

Date Published: Jun 17 2015
A small but fast growing market, we expect the medical device market to expand by a CAGR of 11.4% per annum to reach USD191.4mn by 2018. Imports account for the majority of the market, as domestic production is limited. Public healthcare sector infrastructure projects are contributing to growth momentum.
 

Headline Industry Forecast 

$1,295.00
Israel Pharmaceuticals and Healthcare Report Q3 2015

Israel Pharmaceuticals and Healthcare Report Q3 2015

Date Published: Jun 17 2015
Drug price cuts and the addition of new pharmaceuticals to the national drug formulary demonstrate the government's commitment to expanding access to healthcare. Healthcare spending will remain elevated despite the fiscal deficit given the sector's importance in social stability.
 

Headline Expenditure Projections 

$1,295.00
Portugal Medical Devices Report Q3 2015

Portugal Medical Devices Report Q3 2015

Date Published: Jun 17 2015
The Portuguese medical device market is the second smallest in Western Europe and per capita expenditure is low by regional standards. Most of the market is accountable to the public sector, which has implemented price cuts in order to contain public health expenditure. Market growth is expected to remain subdued, with low prices and lower volume purchases. Small and medium-sized companies have to deal with large debts owed by public hospitals.
 

Headline Industry Forecasts 

$1,295.00
Italy Pharmaceuticals and Healthcare Report Q3 2015

Italy Pharmaceuticals and Healthcare Report Q3 2015

Date Published: Jun 17 2015
Drugmakers will continue to face revenue earning challenges in Italy. In 2014, spending by Italy's national healthcare service, Servizio Sanitario Nazionale (SSN), fell for the seventh consecutive year in which SSN spending on drugs declined. SSN pharmaceutical expenditure will decline in 2015 - creating further revenue pressures for drugmakers as well as pharmacies in Italy and increasing out-of-pocket costs for the population.
 
$1,295.00
Qatar Medical Devices Report Q3 2015

Qatar Medical Devices Report Q3 2015

Date Published: Jun 17 2015
Qatar is a small but rich country with an increasingly attractive medical device market in spite of its limited population size. Per capita expenditure is high, ranking second in the Middle East & Africa. The healthcare sector is being extended and reformed, as part of the Qatar National Vision 2030 and the National Development Strategy 2011-2016. Lower hydrocarbon prices present no immediate threat to Qatar's infrastructure investments and economic performance, therefore opportunities exist for medical device multinationals in the coming years.
$1,295.00

Pages

Shopping cart

0 Items $0.00
Not able to find what you are looking for?
Call Us
WHY CHOOSE MARKET RESEARCH REPORTS?
1
Trusted By Leaders
2
Shop With Confidence
3
Customer Centric
4
Personalized Solutions
5
Secure Checkout

User login

Clients Who Trust Us

Orange, Google, Microsoft, Barclays, CassidianIntel, TPG, Elit Net, Cross Business Producers, AcmavolpakP&G, Cisco, Gemalto, General Insurance Corporation of India, Aviva, Cognizant, InoxWindB. Braun, Cobham, fiserv, Harris, Wipro, AonAl Meera, Nomura Research Institute, Tata Consultancy Services, Amara Raja, Hiranandani EnergyMunich Re, Lotte Chemical, National Post, First Data